The collaboration aims to allow clinicians to capture, analyse and respond to patient data almost in real-time.

Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...

Bile reflux gastritis (BRG) is a gastro-intestinal condition especially characterized by the reflux of bile into the stomach, further leading to mucosal inflammation along with various other clinical ...

While many sites expressed an interest in sustainability, most lacked the bandwidth to support our data collection efforts. For utilities consumption at the trial site and at other sites (eg, clinical ...

The global clinical trials market was valued at USD 60.56 billion in 2024 and is predicted to surge USD 92.12 billion by 2033 with a registered CAGR of 4.84% during the forecast period 2024 to 2033.

Blockchain Technology in Healthcare Market Report By Application (Supply Chain Management, Patient Data Management, Drug Traceability, Clinical Trials & Data Security, Claims Adjudication, Billing, ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markersFull analysis of Phase 2 ...

Axsome Therapeutics demonstrated robust revenue growth in Q4 2024, outpacing expectations despite higher-than-anticipated ...

Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing peptide-based drugs, stands at a pivotal juncture in its ...

Market OverviewThe Clinical Workflow Solutions Market has been witnessing significant growth in recent years, driven by ...

Advanced Machine Learning Models for Gender-Specific Antidepressant Response Prediction: Overcoming Data Imbalance for Precision Psychiatry Depressive disorders are complex, multifactorial conditions ...